Cargando…

Stroke after SARS-CoV-2 vaccination: Comment

Detalles Bibliográficos
Autores principales:	Kleebayoon, Amnuay, Mungmunpuntipantip, Rujittika, Wiwanitkit, Viroj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo 2023
Materias:	Comments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368757/ https://www.ncbi.nlm.nih.gov/pubmed/37454535 http://dx.doi.org/10.1016/j.clinsp.2023.100246

Ejemplares similares

Inactivated (SARS-CoV-2 Vaccine, Retrobulbar Vascular Blood Flow and Retinal Vascular Density
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

SARS-CoV-2 vaccination for unexpected death from atrial myocarditis: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Post-Vaccine SARS-CoV-2 Reinfection and Associated Factors Among Health Care Providers: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Placental damage in pregnant women with SARS-CoV-2 infection: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Comment on the effectiveness of four SARS-COV-2 vaccines
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

SARS CoV-2 vaccine AND rituximab. Comment on: “SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response” by Verhoeven Joint Bone Spine. 2021;88:105258
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Correspondence on SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Antineutrophil cytoplasmic antibody, glomerulonephritis and inactivated SARS‐CoV‐2 vaccine: comment on the article by Garcia et al
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Comment on “immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Seroconversion after Inactive SARS-CoV-2 Vaccination and Obesity: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Hemophagocytic lymphohistiocytosis and SARS-CoV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Subacute thyroiditis and different SARS-CoV-2 vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Polymorphism of tmprss2 (rs12329760) and severity of COVID-19 in the Ukrainian population: comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Venous sinus thrombosis after the second dose of SARS-CoV-2 vaccine administration
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Sinopharm Vaccine, SARS-CoV-2 Breakthrough Infections and Hemoglobinopathies
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

SARS-CoV-2 infection, vaccination and acquired hemophilia: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Drug induced hepatitis and SARS-CoV-2 vaccination: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Correspondence on “Lack of vaccination in ventilated patients for SARS-CoV-2 in France”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Central diabetes insipidus, hypophysitis and SARS-CoV-2 vaccine: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Post-SARS-CoV-2 vaccination COVID toes and fingers correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Correspondence: ChatGPT and scientific writing
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

SARS-CoV-2 mRNA vaccination, prostate cancer and steroids: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Development of myocarditis and pericarditis after COVID‐19 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Acute myocarditis after administration of COVID-19 vaccine: comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Correspondence on anti-SARS-CoV-2 antibodies and clinical outcome of hospitalized COVID-19 patients
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Delayed skin reactions and mRNA vaccines against SARS-CoV-2: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

SARS-CoV-2 Transmission and Vaginal Delivery
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

COVID-19 vaccines and retinal microvasculature: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Comment on Determinants of the Attitude to COVID-19 Vaccine
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Singing Voice Symptomatology and SARS-CoV-2 Infection: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

COVID-19 vaccine-associated autoimmune disorders: Comments
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 vaccination uptake in people with epilepsy: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Acute disseminated encephalomyelitis and COVID-19 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Assessment of psychological distress & COVID-19 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 vaccine type and Guillain-Barré syndrome: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Acute interstitial nephritis following COVID-19 vaccination
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

A commentary on “post-SARS-CoV-2-vaccine shoulder pain: Is it relevant to the vaccine injection? – Correspondence” (int J surg 2022;100:106603)
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

COVID-19 vaccination and idiopathic sudden sensorineural hearing loss: comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Willingness of college students to receive COVID-19 heterologous vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bub40036mge56kr2tgrq5l8okf